Understanding Mycoplasma Genitalium: The Emerging STD
Sexually transmitted diseases have been one of the major talk points in public health for a long period, with famous infections like chlamydia, gonorrhea, and syphilis headlining prevention and treatment talks. However, there is a lesser-known but fast-rising STD: Mycoplasma genitalium, or M. genitalium.
It has been a big concern in the medical community despite its small size, since serious health complications are associated with it, it can manifest asymptomatic in most cases, and the infections usually resist standard antibiotic treatment. The understanding of Mycoplasma genitalium is very important to one who wants to take control over their sexual life.
This article discusses what M. genitalium is, its causes, symptoms, risks, and ways of treatment, with steps that will help you stay current and protected.
22 November 2024
7 min read
271
Mycoplasma Genitalium: What Is It?
Mycoplasma genitalium is a very small bacterium that was first described in the early 1980s. It is among the smallest free-living organisms, which makes the detection and study of this organism difficult. Despite its small size, M. genitalium may cause serious health issues, especially in the genital and urinary tracts.
This bacterium belongs to the category of sexually transmitted infections and is usually transmitted through sexual intercourse, including vaginal, anal, and oral sex. It can affect both men and women, who often do not show noticeable symptoms, thus making it one of the silent but dangerous STDs.
Symptoms of Mycoplasma Genitalium
One of the complications of Mycoplasma genitalium is that it is most often asymptomatic, which means the majority of people infected will not have easily noticeable symptoms. Those who do have symptoms have varied presentations depending on their sex:
In Women:
Abnormal vaginal discharge
Painful intercourse
Pelvic pain
Bleeding between periods
Burning during urination
In Men:
Urethritis, or inflammation of the urethra
Discharge from the penis
Painful urination or burning
Testicular pain, in severe cases
If left untreated, complications from M. genitalium include the more serious health conditions of pelvic inflammatory disease (PID) for women, possibly affecting fertility, and persistent urethritis in men.
M. Genitalium is a relatively less publicized STD, but its risks are just as serious:
Antibiotic Resistance
This is a major problem with M. genitalium as they are increasingly resistant to standard antibiotics. Misdiagnosis or partial treatment can lead to the emergence of drug-resistant strains.
Pelvic Inflammatory Disease
In women, untreated M. genitalium can lead to pelvic inflammatory disease (PID), making the victims susceptible to an ectopic pregnancy and infertility. Persistent infections can also lead to a rise in problems with urethritis in men.
Coinfections
Most people infected with M. genitalium also have co-infections, such as chlamydia or gonorrhea, exacerbating health outcomes.
Lack of Public Awareness
The widespread lack of routine testing and public awareness for M. genitalium means many infections are never diagnosed and treated.
Prevention Strategies
The preventive measure against Mycoplasma genitalium involves safe sexual practices and being responsible enough to seek out regular testing. Here are some important strategies to prevent the disease:
Practice Safe Sex
Use condoms always during vaginal, anal, and oral sexual activities to reduce the chances of infection.
Do not share sex toys or clean them properly after every use.
Regular Testing
Since M. genitalium often appears asymptomatic, regular testing for STDs is essential, especially for those sexually active with multiple partners.
Request a specific test for M. genitalium, as it is not always included in standard STD panels.
Open Communication
Discuss sexual health with your partner(s) and encourage getting tested together.
Knowing the facts and being open will help prevent undiagnosed and untreated infections.
Complete Treatment
If infected, complete the treatment provided and avoid sexual contact until a healthcare provider has confirmed that the infection has been cured.
Testing and Diagnosis
Testing for Mycoplasma genitalium requires advanced laboratory methods since it is a hard bacterium to pinpoint with traditional diagnostic tools. Here's what you need to know about these tests:
NAATs (Nucleic Acid Amplification Tests): NAATs are considered the most reliable way of detecting M. genitalium. This type of test looks for the genetic material of the bacterium in the urine or genital swab specimen.
Symptom-Based Testing: Testing for M. genitalium is also done in individuals with symptoms, such as urethritis that does not resolve or recurring pelvic pain, as part of a diagnostic workup.
Specialized Testing: M. genitalium testing might not be widely available in every clinic or home testing kit, so, in case of suspicion, one needs to ask specifically for the same.
Treatment Options
Treatment of Mycoplasma genitalium has become increasingly challenging because of developing antibiotic resistance. Whereas early infections were readily treated with usual antibiotics, resistance has made the need for targeted therapies paramount:
Macrolides (e.g., Azithromycin)
Generally used as a first-line therapy; however, resistance to macrolides is on the rise.
Fluoroquinolones (e.g., Moxifloxacin)
Generally used when macrolides are ineffective. This is usually reserved for more resistant varieties.
Test of Cure
In some instances, this may involve follow-up testing after treatment to confirm that the infection has been eliminated, considering the possibility of resistance.
Tailored Treatment Plans
Healthcare professionals may employ resistance testing to identify which antibiotic treatment will best suit a particular case.
Frequently Asked Questions
1. What is Mycoplasma genitalium?
Mycoplasma Genitalium is a sexually transmitted bacterium that causes infections of the genital and urinary tracts; it is generally asymptomatic but may lead to severe health problems if not treated.
2. How prevalent is Mycoplasma genitalium?
Surveys suggest M. genitalium may be more common than initially thought, since up to 1–2% of the general population seems to be infected.
3. How does Mycoplasma genitalium get transmitted?
It can be sexually transmitted by sexual exposure, including vaginal, anal, and oral intercourse.
4. Can Mycoplasma genitalium be prevented?
Prevention may be achieved through practicing safe sex, using condoms, and undergoing regular checkups for sexually transmitted diseases.
5. Is Mycoplasma genitalium treatable?
Yes, treatment is possible with antibiotics, but due to the alert of antibiotic resistance raised during treatment, special medication may be needed.
6. What are the symptoms of Mycoplasma genitalium?
Symptoms include pains when urinating, discharge, and pelvic pains, but very often, no symptoms at all occur.
7. How is Mycoplasma genitalium diagnosed?
Testing generally entails the use of NAATs, which detect the genetic material of the bacterium in a urine sample or swab.
8. Can Mycoplasma genitalium cause infertility?
Yes, if left untreated, M. genitalium could lead to pelvic inflammatory disease in women, which may affect fertility.
9. Are at-home test kits available for Mycoplasma genitalium?
Some home-testing kits for STDs include M. genitalium, but it should be checked in advance of purchase.
10. What is my course of action if my test result comes out positive for Mycoplasma genitalium?
Immediately see a healthcare provider for confirmation and treatment. It is important to avoid any sexual activity until one completes the treatment.
Take Responsibility for Your Sexual Health Today!
Mycoplasma genitalium is an emerging STD, which is sneaky and also developing resistance to antibiotics. Thus, this demands attention and necessitates that one gets informed, practices safe sex, and prioritizes testing regularly to protect oneself and partners from potential complications.
Take responsibility for sexual health today. Learn about your testing options, and strive to raise awareness of this silent threat. The key is to keep the prevalence of the disease as low as possible through early detection and effective treatment.
For Men & Women
Results in Minutes
No Lab Needed
Private & Discreet
